Development of a Reverse Transcription Recombinase Polymerase Amplification CRISPR/Cas12a Assay for Visual and Highly Specific Identification of Zika Virus
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Xiao Cong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplant Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Zika Virus, Zika Virus Infection, CRISPR-Cas Systems, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, Natural Science Foundation of Guangdong Province, Guangdong Provincial Center for Disease Control and Prevention Supports Talent Projects.
Abstract (Originalsprache)
Zika virus (ZIKV), a single‐stranded positive‐sense RNA virus of the Flaviviridae family ( Flavivirus genus), causes acute febrile illness and severe congenital anomalies. Serological cross‐reactivity with Dengue virus (DENV) and Chikungunya virus (CHIKV) complicates diagnosis, underscoring the urgency of developing specific point‐of‐care tests for early detection, outbreak mitigation, and reduced misdiagnosis risks. This study established and optimized an RPA–CRISPR/Cas12a assay for the rapid, visual, and highly specific detection of ZIKV. Primers and crRNAs targeting the highly conserved capsid (C) gene were designed, and the assay was systematically evaluated for its specificity, sensitivity, reproducibility, and clinical applicability. The RPA–CRISPR/Cas12a assay enabled naked‐eye detection under UV light within 35 min. It demonstrated single‐copy sensitivity (1 copy/μL), no cross‐reactivity with DENV 1–4, CHIKV, or Japanese encephalitis virus (JEV), and 100% concordance with RT‐qPCR in clinical validation. Repeatability tests showed low variability (coefficient of variation (C.V.) < 15%), confirming robust reproducibility. This instrument‐free platform integrates rapid visual detection, single‐copy sensitivity, high specificity, and field‐deployable features, making it particularly suitable for point‐of‐care testing (POCT) in resource‐limited settings. The developed assay provides critical support for early outbreak containment and prenatal screening in ZIKV‐endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organ Transplant Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Institute of Pathogenic Microbiology, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Workstation for Emerging Infectious Disease C…
ORCID-Profile: Xiao Cong, Junqi Huang
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- Natural Science Foundation of Guangdong Province
- Guangdong Provincial Center for Disease Control and Prevention Supports Talent Projects
- Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response
- Medical Scientific Research Foundation of Guangdong Province, China
- Talent Support Program of Guangdong Provincial Center for Disease Control and Prevention
Zitieren
APA
Cong, X., Zhang, X., Gu, F., Tan, N., Huang, S., Jia, P., Su, J., Sun, C., Tan, Q., Fang, L., Wang, J., Yan, J., Yu, C., Li, B., & Huang, J. (2026). Development of a Reverse Transcription Recombinase Polymerase Amplification CRISPR/Cas12a Assay for Visual and Highly Specific Identification of Zika Virus. Journal of Medical Virology. https://doi.org/10.1002/jmv.70917
Vancouver
Cong X, Zhang X, Gu F, Tan N, Huang S, Jia P, et al. Development of a Reverse Transcription Recombinase Polymerase Amplification CRISPR/Cas12a Assay for Visual and Highly Specific Identification of Zika Virus. Journal of Medical Virology. 2026. doi:10.1002/jmv.70917
BibTeX
@article{Cong2026,
author = {Cong, Xiao and Zhang, Xin and Gu, Feng and Tan, Ningxin and Huang, Shen and Jia, Penghui and Su, Juan and Sun, Changyun and Tan, Qiqi and Fang, Ling and Wang, Jieling and Yan, Jin and Yu, Chao and Li, Baisheng and Huang, Junqi},
title = {Development of a Reverse Transcription Recombinase Polymerase Amplification CRISPR/Cas12a Assay for Visual and Highly Specific Identification of Zika Virus},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70917}
}
EUVIMED